KESKİN, O. Et Al. 2017. In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B. INTERNATIONAL LIVER CONGRESS 2017 .

KESKİN, O., İDİLMAN, R., KALKAN, Ç., KARAKAYA, M. F., ÇALIŞKAN KARTAL, A., & YURTAYDIN, S. C., (2017). In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B . INTERNATIONAL LIVER CONGRESS 2017

KESKİN, ONUR Et Al. "In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B," INTERNATIONAL LIVER CONGRESS 2017, 2017

KESKİN, ONUR Et Al. "In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B." INTERNATIONAL LIVER CONGRESS 2017 , 2017

KESKİN, O. Et Al. (2017) . "In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B." INTERNATIONAL LIVER CONGRESS 2017 .

@conferencepaper{conferencepaper, author={ONUR KESKİN Et Al. }, title={In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B}, congress name={INTERNATIONAL LIVER CONGRESS 2017}, city={}, country={}, year={2017}}